Net Cash Provided by (Used in) Financing Activities of AMGEN INC from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
AMGEN INC annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • AMGEN INC Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $4,107,000,000, a 140% decline year-over-year.
  • AMGEN INC annual Net Cash Provided by (Used in) Financing Activities for 2025 was $10,859,000,000, a 15% decline from 2024.
  • AMGEN INC annual Net Cash Provided by (Used in) Financing Activities for 2024 was $9,415,000,000, a 145% decline from 2023.
  • AMGEN INC annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21,048,000,000.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

AMGEN INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $10,859,000,000 -$1,444,000,000 -15% 01 Jan 2025 31 Dec 2025 10-K 13 Feb 2026 2025 FY
2024 $9,415,000,000 -$30,463,000,000 -145% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2026 2025 FY
2023 $21,048,000,000 +$25,085,000,000 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2026 2025 FY
2022 $4,037,000,000 +$4,234,000,000 +51% 01 Jan 2022 31 Dec 2022 10-K 14 Feb 2025 2024 FY
2021 $8,271,000,000 -$3,404,000,000 -70% 01 Jan 2021 31 Dec 2021 10-K 14 Feb 2024 2023 FY
2020 $4,867,000,000 +$10,900,000,000 +69% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023 2022 FY
2019 $15,767,000,000 +$6,723,000,000 +30% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 $22,490,000,000 -$15,896,000,000 -241% 01 Jan 2018 31 Dec 2018 10-K 09 Feb 2021 2020 FY
2017 $6,594,000,000 -$3,995,000,000 -154% 01 Jan 2017 31 Dec 2017 10-K 12 Feb 2020 2019 FY
2016 $2,599,000,000 +$1,172,000,000 +31% 01 Jan 2016 31 Dec 2016 10-K 13 Feb 2019 2018 FY
2015 $3,771,000,000 -$497,000,000 -15% 01 Jan 2015 31 Dec 2015 10-K 13 Feb 2018 2017 FY
2014 $3,274,000,000 -$5,765,000,000 -231% 01 Jan 2014 31 Dec 2014 10-K 14 Feb 2017 2016 FY
2013 $2,491,000,000 +$2,072,000,000 +495% 01 Jan 2013 31 Dec 2013 8-K 31 Oct 2016
2012 $419,000,000 +$1,093,000,000 01 Jan 2012 31 Dec 2012 10-K 19 Feb 2015 2014 FY
2011 $674,000,000 +$558,000,000 +45% 01 Jan 2011 31 Dec 2011 10-K 24 Feb 2014 2013 FY
2010 $1,232,000,000 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2013 2012 FY

AMGEN INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,107,000,000 -$2,399,000,000 -140% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q1 2024 $1,708,000,000 -$23,217,000,000 -108% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q1 2023 $21,509,000,000 +$25,023,000,000 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q1 2022 $3,514,000,000 -$1,575,000,000 -81% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023 2023 Q1
Q1 2021 $1,939,000,000 -$1,685,000,000 -663% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022 2022 Q1
Q1 2020 $254,000,000 +$4,733,000,000 +95% 01 Jan 2020 31 Mar 2020 10-Q 28 Apr 2021 2021 Q1
Q1 2019 $4,987,000,000 +$6,705,000,000 +57% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020 2020 Q1
Q1 2018 $11,692,000,000 -$9,581,000,000 -454% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $2,111,000,000 -$3,338,000,000 -272% 01 Jan 2017 31 Mar 2017 10-Q 25 Apr 2018 2018 Q1
Q1 2016 $1,227,000,000 +$2,624,000,000 01 Jan 2016 31 Mar 2016 10-Q 27 Apr 2017 2017 Q1
Q1 2015 $1,397,000,000 -$902,000,000 -182% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016 2016 Q1
Q1 2014 $495,000,000 +$3,090,000,000 +86% 01 Jan 2014 31 Mar 2014 10-Q 27 Apr 2015 2015 Q1
Q1 2013 $3,585,000,000 -$2,220,000,000 -163% 01 Jan 2013 31 Mar 2013 10-Q 30 Apr 2014 2014 Q1
Q1 2012 $1,365,000,000 +$1,131,000,000 +45% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013 2013 Q1
Q1 2011 $2,496,000,000 -$1,920,000,000 -333% 01 Jan 2011 31 Mar 2011 10-Q 08 May 2012 2012 Q1
Q1 2010 $576,000,000 01 Jan 2010 31 Mar 2010 10-Q 10 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.